Visual outcomes and patient satisfaction in refractive lens exchange with trifocal intraocular lens in presbyopic hyperopia, emmetropia, and myopia

Evidence database / Studies / rausell-2026-rayone-trifocal-rle

—enrolled patients*

—enrolled eyes*

3structured arms

90maximum standardized days follow-up

* Descriptive sum of reported arm counts. “≥” indicates that one or more arm counts were not reported; missing values are not treated as zero.

Study arm

Myopic presbyopia

RLERayOne Trifocal

Population

Patients: Not reported
Eyes: Not reported
Bilateral treatment: Not reported
Age range: Not reported
Sphere range: Not reported
Cylinder range: Not reported
Spherical equivalent: Not reported
Corneal thickness: Not reported

Eligibility definition

Inclusion
Presbyopic myopic eyes receiving bilateral RLE with RayOne Trifocal IOL.

Exclusion
Not structured

Reported outcomes by follow-up

Outcome	Follow-up	Follow-up sample	Result	Reported fraction	Provenance
Mean postoperative spherical equivalent refractive	3 months	—	-0.05 D	Not reported	VERIFIED Source

Complications

No structured complication observations are available for this arm. This means “not reported in this dataset,” not zero complications.

Study arm

Emmetropic presbyopia

RLERayOne Trifocal

Population

Patients: Not reported
Eyes: Not reported
Bilateral treatment: Not reported
Age range: Not reported
Sphere range: Not reported
Cylinder range: Not reported
Spherical equivalent: Not reported
Corneal thickness: Not reported

Eligibility definition

Inclusion
Presbyopic emmetropic eyes receiving bilateral RLE with RayOne Trifocal IOL.

Exclusion
Not structured

Reported outcomes by follow-up

Outcome	Follow-up	Follow-up sample	Result	Reported fraction	Provenance
Mean postoperative spherical equivalent refractive	3 months	—	-0.05 D	Not reported	VERIFIED Source

Complications

No structured complication observations are available for this arm. This means “not reported in this dataset,” not zero complications.

Study arm

Hyperopic presbyopia

RLERayOne Trifocal

Population

Patients: Not reported
Eyes: Not reported
Bilateral treatment: Not reported
Age range: Not reported
Sphere range: Not reported
Cylinder range: Not reported
Spherical equivalent: Not reported
Corneal thickness: Not reported

Eligibility definition

Inclusion
Presbyopic hyperopic eyes receiving bilateral RLE with RayOne Trifocal IOL.

Exclusion
Not structured

Reported outcomes by follow-up

Outcome	Follow-up	Follow-up sample	Result	Reported fraction	Provenance
Mean postoperative spherical equivalent refractive	3 months	—	-0.08 D	Not reported	VERIFIED Source

Complications

No structured complication observations are available for this arm. This means “not reported in this dataset,” not zero complications.

Study design

Retrospective comparative case series with three-month follow-up after bilateral RLE.

Country: Not reported
Publication-reported places: Not reported
Multicenter: Not reported
Prospective: No
Randomized: No
Source type: RETROSPECTIVE
Regulator: Not reported

Place metadata may refer to a treatment site, institution or author affiliation. Confirm its role in the linked publication.

Limitations and notes

The source reports 6,788 eyes overall but does not provide refractive-group denominators in the abstract.

Missing fields are not interpreted as negative findings. Arm counts may not be additive in all study designs.

Study evidence level
A simple, non-GRADE hierarchy based on design: randomized and large regulatory trials are high; prospective cohorts moderate; retrospective observational studies low. Manual review can override this label.